IMRN - Immuron Limited -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Immuron Limited
Immuron Ltd is a biopharmaceutical company which develops polyclonal antibodies for the treatment and prevention of diseases. It products include Travelan, IMM-124E for NASH and IMM-529 for Clostridium difficile infection.
IPO Date: June 9, 2017
Sector: Healthcare
Industry: Biotech
Related Tickers:
AMGN GILD VRTX REGN MRNA ARGX IQV RVMD ONC BIIB
Market Cap: $6.94M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.17 | 4.40%
Avg Daily Range (30 D): $0.04 | 4.27%
Avg Daily Range (90 D): $0.06 | 5.17%
Institutional Daily Volume
Avg Daily Volume: .27M
Avg Daily Volume (30 D): .04M
Avg Daily Volume (90 D): 1.45M
Trade Size
Avg Trade Size (Sh.): 184
Avg Trade Size (Sh.) (30 D): 224
Avg Trade Size (Sh.) (90 D): 247
Institutional Trades
Total Institutional Trades: 9
Avg Institutional Trade: $1.08M
Avg Institutional Trade (30 D): $.66M
Avg Institutional Trade (90 D): $.66M
Avg Institutional Trade Volume: .11M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $M
Avg Closing Volume: K
 
News
Oct 22, 2026 @ 10:27 PM
Immuron CEO, Steven Lydeamore presentation at Emer...
Source: Immuron Limited
Jul 16, 2026 @ 10:00 AM
Immuron FY26 Sales - Four Consecutive Quarters of ...
Source: Na
Jul 6, 2026 @ 10:00 AM
Immuron Advances IMM-529 (Clostridioides difficile...
Source: Immuron Limited
Apr 17, 2026 @ 10:00 AM
Immuron Double Digit 3Q Sales Growth
Source: Not Specified
Feb 25, 2026 @ 11:00 AM
Immuron Reports HY26 Results and Strategic Reset
Source: Not Specified